HomeACE • STO
add
Ascelia Pharma AB
Previous close
kr 4.22
Day range
kr 4.00 - kr 4.32
Year range
kr 2.00 - kr 11.68
Market cap
474.54M SEK
Avg Volume
931.70K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 20.33M | 19.05% |
Net income | -21.73M | -30.18% |
Net profit margin | — | — |
Earnings per share | -0.23 | 54.00% |
EBITDA | -20.31M | -19.07% |
Effective tax rate | 0.61% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 57.30M | 115.88% |
Total assets | 122.98M | 33.49% |
Total liabilities | 65.16M | 122.79% |
Total equity | 57.82M | — |
Shares outstanding | 94.49M | — |
Price to book | 6.92 | — |
Return on assets | -38.52% | — |
Return on capital | -53.68% | — |
Cash Flow
Net change in cash
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -21.73M | -30.18% |
Cash from operations | -16.92M | -12.38% |
Cash from investing | — | — |
Cash from financing | -229.00K | -101.21% |
Net change in cash | -17.96M | -483.10% |
Free cash flow | -11.50M | -45.44% |
About
Founded
1999
Website
Employees
11
